rs776459318
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_015450.3(POT1):c.623G>A(p.Ser208Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,458,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015450.3 missense
Scores
Clinical Significance
Conservation
Publications
- pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- tumor predisposition syndrome 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- glioma susceptibility 9Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- thyroid gland carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- cerebroretinal microangiopathy with calcifications and cysts 3Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POT1 | NM_015450.3 | c.623G>A | p.Ser208Asn | missense_variant | Exon 9 of 19 | ENST00000357628.8 | NP_056265.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000240 AC: 6AN: 250308 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1458430Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 725624 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28393830) -
Tumor predisposition syndrome 3 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 208 of the POT1 protein (p.Ser208Asn). This variant is present in population databases (rs776459318, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with POT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 541869). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POT1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.S208N variant (also known as c.623G>A), located in coding exon 5 of the POT1 gene, results from a G to A substitution at nucleotide position 623. The serine at codon 208 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at